Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Biomedical Science|February 24, 2006
Crosstalk between hepatocyte growth factor and integrin signaling pathwaysPo-Chao Chan, Shu-Yi Chen, Chun-Hwa Chen, et al.Chemmedchem|March 26, 2014
Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approachYung Chang Hsu, Yi-Yu Ke, Hui-Yi Shiao, et al.European Journal of Medicinal Chemistry|August 31, 2016
Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug designChun-Feng Chang, Wen-Hsing Lin, Yi-Yu Ke, et al.Scientific Reports|June 30, 2015
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identificationYi-Yu Ke, Vivek Kumar Singh, Mohane Selvaraj Coumar, et al.European Journal of Medicinal Chemistry|June 25, 2014
Ligand efficiency based approach for efficient virtual screening of compound librariesYi-Yu Ke, Mohane Selvaraj Coumar, Hui-Yi Shiao, et al.Scientific Reports|June 17, 2015
Anchor-based classification and type-C inhibitors for tyrosine kinasesKai-Cheng Hsu, Tzu-Ying Sung, Chih-Ta Lin, et al.Iscience|July 11, 2022
Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular traffickingChih-Feng Tien, Wan-Ting Tsai, Chun Hwa Chen, et al.Journal of Medicinal Chemistry|January 15, 2009
Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificityMohane Selvaraj Coumar, Jiun-Shyang Leou, Paritosh Shukla, et al.Anticancer Research|January 4, 2012
A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitorsWen-Hsing Lin, Jen-Shin Song, Tzu-Wen Lien, et al.Plos One|January 14, 2014
Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancerWen-Hsing Lin, Teng-Kuang Yeh, Weir-Torn Jiaang, et al.Pageof 3